APA (7th ed.) Citation

Koole, S. N., Vessies, D. C. L., Schuurbiers, M. M. F., Kramer, A., Schouten, R. D., Degeling, K., . . . Retèl, V. P. (2022). Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers, 14(7), 1783. https://doi.org/10.3390/cancers14071783

Chicago Style (17th ed.) Citation

Koole, Simone N., et al. "Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance." Cancers 14, no. 7 (2022): 1783. https://doi.org/10.3390/cancers14071783.

MLA (9th ed.) Citation

Koole, Simone N., et al. "Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance." Cancers, vol. 14, no. 7, 2022, p. 1783, https://doi.org/10.3390/cancers14071783.